Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis

Conclusions: Our analysis of a large international registry demonstrates that nonadherence with evidence-based secondary prevention therapies in patients with established atherothrombosis is associated with a significant increase in long-term adverse events, including mortality.

Source: The American Journal of Medicine - June 24, 2013 Category: Journals (General) Authors: Dharam J. Kumbhani, Ph. Gabriel Steg, Christopher P. Cannon, Kim A. Eagle, Sidney C. Smith, Elaine Hoffman, Shinya Goto, E. Magnus Ohman, Deepak L. Bhatt, REduction of Atherothrombosis for Continued Health Registry Investigators Tags: Clinical research studies Source Type: research